About this webinar

Previous research has highlighted the gender discrepancies in hepatitis C care between men and women. In this seminar, Heather Valerio provided an epidemiological overview of the progress made towards hepatitis C elimination in Australia while highlighting the specific factors that influence testing and treatment among women who inject drugs. Alison then contextualised these results by presenting a qualitative study that examines the gender-specific barriers to hepatitis C care that are experienced among women who inject drugs. Danielle Russel joined the panel discussion and Q&A following these presentations.

About the speakers

Heather Vallerio joined the Viral Hepatitis Clinical Research Program at the Kirby Institute as a PhD candidate in 2018 after working in Blood Borne Virus epidemiology and surveillance among people who inject drugs in Glasgow, United Kingdom. She is now a postdoctoral research fellow in the same team at the Kirby, where she analyses a large, population-level data linkage study to understand the progress towards hepatitis C elimination in marginalised populations.

Alison Marshall is a lecturer at the Kirby Institute and the Centre for Social Research in Health at UNSW Sydney. Her research primarily focuses on how to increase access to hepatitis C testing and treatment among people who inject drugs.